The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
First Solar, Inc. (Nasdaq: FSLR) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Net sales for the first
22.04.2024 - Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million,
18.04.2024 - First quarter 2024 net income of $26.1 million and net income available to common stockholders of $21.8 million, or $0.46 per diluted share First quarter 2024 growth in loans held for investment of 2.4% and in total deposits of 7.1%
Revenue of $4.8 billion declined 1.1% year-over-year, or declined 1.2% in constant currency1, which was above the high-end of our guidance range Operating
NEW YORK, May 01, 2024--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6).
The latest reading is the highest hunger incidence since May 2021, when SWS recorded 16.8%.
Aptar Reports First Quarter 2024 Results. AptarGroup, Inc. (NYSE:ATR), a
Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion.
GAAP earnings per share was $0.73; operating earnings per share (EPS)1 was
Meta Platforms, Inc. (Nasdaq: META) today reported financial results for
Veralto (NYSE: VLTO) (the "Company"), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resources™ announced results for the first quarter ended March 29, 2024.